Prime Therapeutics Executive and Leadership Team

Timothy Vines, the President & Chief Executive Officer at Prime Therapeutics, directs the overall strategic vision and operational execution of the pharmacy benefit management company. Vines champions the organization's mission to prioritize people over profits, driving innovative pharmacy solutions that enhance medication access, affordability, and adherence for employers, health plans, consultants, and unions. Overseeing the integration of expert clinical support for chronic health conditions and specialty drugs, Timothy Vines ensures a holistic and transparent approach to pharmacy benefits. This leadership role involves steering the company's transformative impact within the healthcare industry, leveraging modern technology and a strong commitment to corporate social responsibility. By setting the executive direction, Vines guides Prime Therapeutics in its pursuit of a more equitable and effective healthcare ecosystem, ensuring all initiatives align with the core values of improving member health outcomes and financial stewardship.

Kenneth Bodmer, the Chief Financial Officer at Prime Therapeutics, manages the company's financial strategy and operations, ensuring fiscal health and sustainable growth. Bodmer oversees all financial planning, budgeting, forecasting, and reporting activities, providing critical insights that support the organization's mission of transforming the PBM model. By prioritizing people over profits, Kenneth Bodmer guides financial decisions to enhance medication access, affordability, and adherence, while also supporting the investment in expert clinical support for chronic conditions and specialty drugs. This role involves managing relationships with financial institutions, investors, and stakeholders, ensuring transparency and accountability across all fiscal matters. Through astute financial management, Kenneth Bodmer drives the company's ability to deliver innovative pharmacy solutions and maintain a holistic approach to pharmacy benefits for its diverse client base, including employers, health plans, consultants, and unions.

Matthew Mertel, the Chief Operating Officer at Prime Therapeutics, directs the company's day-to-day operations and service delivery, ensuring efficiency and excellence across all functional areas. Mertel oversees the execution of pharmacy benefit management services, focusing on optimizing processes that improve medication access, affordability, and adherence for members. By driving operational improvements, Matthew Mertel supports the company's commitment to prioritizing people over profits and transforming the PBM model. This role involves managing key operational teams, including member services, claims processing, and network management, ensuring seamless integration with expert clinical support for chronic conditions and specialty drugs. Through effective operational leadership, Matthew Mertel ensures Prime Therapeutics delivers a transparent and holistic approach to pharmacy benefits, meeting the needs of employers, health plans, consultants, and unions with reliable and innovative solutions.

David Schlett, the President, Business Transformation & Strategic Initiatives at Prime Therapeutics, drives the company's efforts to modernize its operations and implement forward-thinking strategies. Schlett leads initiatives focused on transforming the PBM model, ensuring that Prime Therapeutics prioritizes people over profits by enhancing medication access, affordability, and adherence. This role is critical in integrating innovative pharmacy solutions and expert clinical support for chronic health conditions and specialty drugs, thereby improving member outcomes. David Schlett oversees the execution of key strategic projects, ensuring a transparent and holistic approach to pharmacy benefits for employers, health plans, consultants, and unions. By championing business transformation, David Schlett positions Prime Therapeutics for sustained growth and impact within the evolving healthcare landscape, reinforcing the company's commitment to innovation and member well-being.

Ellyn Hosch, the Chief Information Officer at Prime Therapeutics, leads the company's technology strategy and digital transformation initiatives. Hosch is responsible for overseeing all aspects of information technology, including infrastructure, cybersecurity, data management, and application development, ensuring robust and secure systems that support the organization's innovative pharmacy solutions. By championing modern technology, Ellyn Hosch enables Prime Therapeutics to improve medication access, affordability, and adherence, while also facilitating the delivery of expert clinical support for chronic health conditions and specialty drugs. This leadership position involves aligning technology investments with the company's core mission of prioritizing people over profits and transforming the PBM model. Through strategic IT leadership, Ellyn Hosch ensures that the company's technological capabilities empower its clients, including employers, health plans, consultants, and unions, with a transparent and holistic approach to pharmacy benefits.

Erin Feigal, the Senior Vice President and Chief Human Resources Officer at Prime Therapeutics, leads the company's human capital strategy and organizational development. Feigal is responsible for cultivating a culture that aligns with Prime Therapeutics' mission of prioritizing people over profits, ensuring a supportive and engaging environment for all employees. This role involves overseeing talent acquisition, employee relations, compensation and benefits, and leadership development, all aimed at supporting the delivery of innovative pharmacy solutions. Erin Feigal plays a crucial part in ensuring that the organization's workforce is equipped to provide expert clinical support for chronic health conditions and specialty drugs, thereby enhancing medication access, affordability, and adherence. By focusing on human resources excellence, Erin Feigal contributes significantly to the company's transformative impact in the healthcare industry and its commitment to a transparent and holistic approach to pharmacy benefits.

Yasmin Samra, the Vice President, Chief of Staff, Market Solutions at Prime Therapeutics, drives strategic initiatives and operational alignment within the market solutions division. Samra works closely with leadership to develop and execute strategies that enhance medication access, affordability, and adherence for employers, health plans, consultants, and unions. By focusing on market-driven innovation, Yasmin Samra supports the company's commitment to transforming the PBM model and prioritizing people over profits. This role involves coordinating cross-functional efforts to deliver tailored pharmacy benefit solutions and ensuring seamless integration with clinical support for chronic conditions and specialty drugs. Through strategic planning and execution, Yasmin Samra contributes to Prime Therapeutics' ability to provide a transparent and holistic approach to pharmacy benefits, fostering strong client relationships and driving market growth.

Amy Van Buren, the Vice President and Chief of Staff, Specialty and Clinical Solutions at Prime Therapeutics, spearheads strategic initiatives within the specialty and clinical services domain. Van Buren focuses on optimizing the delivery of expert clinical support for managing chronic health conditions and specialty drugs, ensuring members receive comprehensive care. This role is critical in enhancing medication adherence and improving health outcomes, directly supporting Prime Therapeutics' mission to transform the PBM model by prioritizing people over profits. Amy Van Buren collaborates with various departments to ensure seamless integration of clinical services with overall pharmacy benefit offerings, contributing to a holistic and transparent approach. By driving innovation in specialty and clinical solutions, Amy Van Buren reinforces the company's commitment to providing high-value pharmacy benefits to employers, health plans, consultants, and unions.

Melinda Smith, the Senior VP & Chief of Staff at Prime Therapeutics, provides strategic leadership and operational support across key organizational functions. Smith works to ensure alignment with the company's core mission of transforming the PBM model by prioritizing people over profits, driving initiatives that enhance medication access, affordability, and adherence. This role involves facilitating communication and collaboration among executive teams, supporting the delivery of innovative pharmacy solutions and expert clinical support for chronic conditions and specialty drugs. Melinda Smith plays a vital part in operationalizing strategic plans, ensuring that Prime Therapeutics maintains a transparent and holistic approach to pharmacy benefits for its diverse client base. By driving operational efficiency and strategic execution, Melinda Smith contributes significantly to the company's overall success and its commitment to improving member health outcomes.

Lanna Niemeyer, the Vice President - Center for Strategic Practices and Chief of Staff at Prime Therapeutics, leads the development and implementation of strategic initiatives aimed at advancing the company's mission. Niemeyer oversees the Center for Strategic Practices, focusing on identifying and executing opportunities that enhance medication access, affordability, and adherence, while supporting expert clinical care for chronic conditions and specialty drugs. This role is integral to transforming the PBM model by prioritizing people over profits, ensuring that strategic decisions align with delivering innovative pharmacy solutions. Lanna Niemeyer works to foster a culture of continuous improvement and strategic foresight, contributing to a transparent and holistic approach to pharmacy benefits. By driving strategic planning and execution, Niemeyer ensures Prime Therapeutics remains at the forefront of healthcare innovation for employers, health plans, consultants, and unions.